POLIO SABIN ONE AND THREE

This brand name is authorized in Nigeria.

Active ingredients

The drug POLIO SABIN ONE AND THREE contains a combination of these active pharmaceutical ingredients (APIs):

1	Poliomyelitis, serotype 1 UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 1
2	Poliomyelitis, serotype 3 UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 3

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0082	Suspension/Drops	Polio Sabin Bivalent Oral Poliomyelitis Vaccine Types 1 and 3 (BOPV) SUSP_DROPS see Composition 2 mL (20 doses) x 100's (in vials)	Oral suspension. The vaccine is presented as a clear liquid, yellowish-to pink suspension for oral administration	04/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BF04		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BF Poliomyelitis vaccines
Discover more medicines within J07BF04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-0082